Exploring dendrimer-based drug delivery systems and their potential applications in cancer immunotherapy

S Mukherjee, S Mukherjee, MAS Abourehab… - European Polymer …, 2022 - Elsevier
Cancer immunotherapy has been researched as a major modality of treatment which
involves activating the immune system of the patient to fight against tumor cells. Dendrimers …

Innovative nanomaterials for cancer diagnosis, imaging, and therapy: Drug delivery applications

M Pourmadadi, MM Eshaghi, S Ostovar… - Journal of Drug Delivery …, 2023 - Elsevier
The emergence of nanomedicine drugs as a result of the fast advancement of
nanotechnology offers enormous potential for improving cancer treatment strategies. The …

Nanomedicine-based delivery strategies for breast cancer treatment and management

P Tagde, A Najda, K Nagpal, GT Kulkarni… - International journal of …, 2022 - mdpi.com
Breast cancer is one of the most common types of cancer among women globally. It is
caused by mutations in the estrogen/progesterone receptors and conventional treatment …

Application of dendrimers in anticancer diagnostics and therapy

Z Bober, D Bartusik-Aebisher, D Aebisher - Molecules, 2022 - mdpi.com
The application of dendrimeric constructs in medical diagnostics and therapeutics is
increasing. Dendrimers have attracted attention due to their compact, spherical three …

Dendrimers as modifiers of inorganic nanoparticles for therapeutic delivery in cancer

M Zenze, A Daniels, M Singh - Pharmaceutics, 2023 - mdpi.com
The formulation of nanoscale systems with well-defined sizes and shapes is of great interest
in applications such as drug and gene delivery, diagnostics and imaging. Dendrimers are …

Recent advances of dendrimers as multifunctional nano-carriers to combat breast cancer

SK Dubey, M Kali, S Hejmady, RN Saha… - European Journal of …, 2021 - Elsevier
Breast Cancer (BC) is a highly heterogeneous malignant carcinoma that is the most
frequently occurring cancer in women. The major types of BC are luminal A, basal-like …

The therapeutic efficacy of dendrimer and micelle formulations for breast cancer treatment

S Alven, BA Aderibigbe - Pharmaceutics, 2020 - mdpi.com
Breast cancer is among the most common types of cancer in women and it is the cause of a
high rate of mortality globally. The use of anticancer drugs is the standard treatment …

Erlotinib-loaded dendrimer nanocomposites as a targeted lung cancer chemotherapy

WK Fatani, FS Aleanizy, FY Alqahtani, MM Alanazi… - Molecules, 2023 - mdpi.com
Lung cancer is the main cause of cancer-related mortality globally. Erlotinib is a tyrosine
kinase inhibitor, affecting both cancerous cell proliferation and survival. The emergence of …

Neratinib for HER2-positive breast cancer with an overlooked option

L Guo, W Shao, C Zhou, H Yang, L Yang, Q Cai… - Molecular …, 2023 - Springer
Positive human epidermal growth factor receptor 2 (HER2) expression is associated with an
increased risk of metastases especially those to the brain in patients with advanced breast …

Engineered nanomaterials as an effective tool for HER2+ breast cancer therapy

P Pandey, DK Arya, MK Ramar, K Chidambaram… - Drug Discovery …, 2022 - Elsevier
Highlights•Breast cancer (BC) is the most aggressive malignant cancer in women
worldwide.•Multidrug resistance (MDR), poor targeting, and high toxicity constrain …